This episode is sponsored by J.P. Morgan.
---
In this episode, I interview Andrew Goldberg, Co-founder and COO of HealthVerity, a software company advancing science by synchronizing transformational technologies with the nation’s largest healthcare and consumer data ecosystem.
HealthVerity was founded to address a critical need in the healthcare industry: to combine disparate datasets in a HIPAA-compliant manner, revealing patient insights and powering innovation.
They leverage innovative technologies to help clients discover, license, and link patient data across their ecosystems as well as a wide range of top-tier data providers.
They empower customers to gain new perspectives on patient activities while ensuring complete privacy management and HIPAA compliance.
When a patient visits a doctor, typically five or six entities know about the visit, each holding a snippet of information about that encounter.
These fragments of a patient's journey exist out in the real world with various data providers.
Companies like HealthVerity step in to federate and bring together these aspects of a patient’s healthcare journey, using real-world data to understand treatment and outcomes.
They created a marketplace where buyers and suppliers can align and conduct transactions at market-clearing prices to access this data in a privacy-protected way.
Also joining us on the episode was Andrew McEvoy, an Executive Director from JP Morgan's Middle Market Healthcare Services team within their commercial investment bank.
His team works exclusively with healthcare providers and health technology organizations across the business lifecycle, from venture-backed startups to scaling billion-dollar-plus operations, offering clients bespoke credit solutions and healthcare specific treasury tools.
Tune into this episode to hear Andrew share his journey building HealthVerity, how he and his team are innovating solutions to uncover the full patient journey, and the significance of HIPAA compliance and privacy protection in healthcare data handling.